Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 May;10(3):192-204.
doi: 10.1111/irv.12363. Epub 2016 Feb 1.

Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis

Stella G Muthuri  1 Sudhir Venkatesan  1 Puja R Myles  1 Jo Leonardi-Bee  1 Wei Shen Lim  2 Abdullah Al Mamun  3 Ashish P Anovadiya  4 Wildo N Araújo  5 Eduardo Azziz-Baumgartner  6 Clarisa Báez  7 Carlos Bantar  8 Mazen M Barhoush  9 Matteo Bassetti  10 Bojana Beovic  11 Roland Bingisser  12 Isabelle Bonmarin  13 Victor H Borja-Aburto  14 Bin Cao  15 Jordi Carratala  16 María R Cuezzo  17 Justin T Denholm  18 Samuel R Dominguez  19 Pericles A D Duarte  20 Gal Dubnov-Raz  21 Marcela Echavarria  22 Sergio Fanella  23 James Fraser  24 Zhancheng Gao  25 Patrick Gérardin  26   27   28   29 Maddalena Giannella  30 Sophie Gubbels  31 Jethro Herberg  32 Anjarath L Higuera Iglesias  33 Peter H Hoeger  34 Matthias Hoffmann  35 Xiaoyun Hu  36 Quazi T Islam  37 Mirela F Jiménez  38 Amr Kandeel  39 Gerben Keijzers  40 Hossein Khalili  41 Gulam Khandaker  42 Marian Knight  43 Gabriela Kusznierz  44 Ilija Kuzman  45 Arthur M C Kwan  46 Idriss Lahlou Amine  47 Eduard Langenegger  48 Kamran B Lankarani  49 Yee-Sin Leo  50 Rita Linko  51 Pei Liu  52 Faris Madanat  53 Toshie Manabe  54 Elga Mayo-Montero  55 Allison McGeer  56 Ziad A Memish  57   58 Gokhan Metan  59 Dragan Mikić  60 Kristin G I Mohn  61   62 Ahmadreza Moradi  63   64 Pagbajabyn Nymadawa  65 Bulent Ozbay  66 Mehpare Ozkan  67 Dhruv Parekh  68 Mical Paul  69 Wolfgang Poeppl  70 Fernando P Polack  71   72 Barbara A Rath  73 Alejandro H Rodríguez  74 Marilda M Siqueira  75 Joanna Skręt-Magierło  76 Ewa Talarek  77 Julian W Tang  78   79   80 Antoni Torres  81 Selda H Törün  82 Dat Tran  83 Timothy M Uyeki  84 Annelies van Zwol  85 Wendy Vaudry  86 Daiva Velyvyte  87 Tjasa Vidmar  88 Paul Zarogoulidis  89 PRIDE Consortium InvestigatorsJonathan S Nguyen-Van-Tam  1
Collaborators, Affiliations
Meta-Analysis

Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis

Stella G Muthuri et al. Influenza Other Respir Viruses. 2016 May.

Abstract

Background: The impact of neuraminidase inhibitors (NAIs) on influenza-related pneumonia (IRP) is not established. Our objective was to investigate the association between NAI treatment and IRP incidence and outcomes in patients hospitalised with A(H1N1)pdm09 virus infection.

Methods: A worldwide meta-analysis of individual participant data from 20 634 hospitalised patients with laboratory-confirmed A(H1N1)pdm09 (n = 20 021) or clinically diagnosed (n = 613) 'pandemic influenza'. The primary outcome was radiologically confirmed IRP. Odds ratios (OR) were estimated using generalised linear mixed modelling, adjusting for NAI treatment propensity, antibiotics and corticosteroids.

Results: Of 20 634 included participants, 5978 (29·0%) had IRP; conversely, 3349 (16·2%) had confirmed the absence of radiographic pneumonia (the comparator). Early NAI treatment (within 2 days of symptom onset) versus no NAI was not significantly associated with IRP [adj. OR 0·83 (95% CI 0·64-1·06; P = 0·136)]. Among the 5978 patients with IRP, early NAI treatment versus none did not impact on mortality [adj. OR = 0·72 (0·44-1·17; P = 0·180)] or likelihood of requiring ventilatory support [adj. OR = 1·17 (0·71-1·92; P = 0·537)], but early treatment versus later significantly reduced mortality [adj. OR = 0·70 (0·55-0·88; P = 0·003)] and likelihood of requiring ventilatory support [adj. OR = 0·68 (0·54-0·85; P = 0·001)].

Conclusions: Early NAI treatment of patients hospitalised with A(H1N1)pdm09 virus infection versus no treatment did not reduce the likelihood of IRP. However, in patients who developed IRP, early NAI treatment versus later reduced the likelihood of mortality and needing ventilatory support.

Keywords: Hospitalisation; individual participant data meta-analyses; influenza-related pneumonia; neuraminidase inhibitors.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study flow diagram. *Two hundred and sixty patients added since publication of Muthuri et al.17 following clarification of inpatient status from data collaborator.
Figure 2
Figure 2
Summary of main findings for influenza‐related pneumonia (IRP) in laboratory‐ and clinical diagnosed influenza patients, all ages.

References

    1. Lee N, Chan PKS, Lui GCY et al Complications and outcomes of pandemic 2009 influenza a (H1N1) virus infection in hospitalized adults: how do they differ from those in seasonal influenza? J Infect Dis 2011; 203:1739–1747. - PubMed
    1. Perez‐Padilla R, de la Rosa‐Zamboni D, Ponce de Leon S et al, Influenza IWGo . Pneumonia and respiratory failure from swine‐origin influenza a (H1N1) in Mexico. N Engl J Med 2009; 361:680–689. - PubMed
    1. Reyes S, Montull B, Martinez R et al Risk factors of a/H1N1 etiology in pneumonia and its impact on mortality. Respir Med 2011; 105:1404–1411. - PubMed
    1. Louie JK, Acosta M, Winter K et al, California Pandemic Working G . Factors associated with death or hospitalization due to pandemic 2009 influenza a(H1N1) infection in California. JAMA 2009; 302:1896–1902. - PubMed
    1. Nguyen‐Van‐Tam JS, Openshaw PJM, Hashim A et al, Influenza Clinical Information N . Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009). Thorax 2010; 65:645–651. - PMC - PubMed

Publication types

MeSH terms